ML307
ML307 is a potent, sub-micromolar, first-in-class Ubc13 enzyme activity inhibitor with an IC50 of 781 nM. ML307 has the potential for immunomodulation and inflammation research[1].
Product Specifications
CAS Number
3058650-52-2
UNSPSC
12352005
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ml307.html
Purity
99.10
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NCC1CCN(CC2=CC(Cl)=CC=C2)CC1)[C@@H]3CCCN(C4=NC=NC5=C4N=C6CCCCN65)C3
Molecular Formula
C28H36ClN7O
Molecular Weight
522.08
References & Citations
[1]Robert Ardecky, et al. Selective UBC 13 Inhibitors. Bethesda (MD) : National Center for Biotechnology Information (US) ; 2010.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Mycobacterium bovis Cell surface glycolipoprotein MPB83 (mpb83)
Recombinant Mycobacterium bovis Cell surface glycolipoprotein MPB83 (mpb83)
Recombinant Mycobacterium bovis Cell surface glycolipoprotein MPB83 (mpb83)
Human Platelet-activating factor acetylhydrolase 2,PAFAH2 ELISA KIT